Ipca Laboratories Limited (NSE:IPCALAB)

Ipca Laboratories Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Total Valuation

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Market Capitalization	492,998	406,231	381,038	313,934	205,589	270,385
Market Cap Growth	45.12%	6.61%	21.38%	52.70%	-23.96%	11.96%
Enterprise Value	503,732	420,860	398,201	338,588	200,771	264,496
Last Close Price	1943.20	1595.66	1494.63	1227.92	802.65	1050.76

Price Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
PE Ratio	37.64	35.60	51.65	57.36	43.62	30.58
Forward PE	31.06	30.94	34.66	35.94	25.68	24.65
PS Ratio	4.87	4.21	4.26	4.07	3.29	4.64
PB Ratio	5.18	4.26	4.54	4.06	3.48	4.88
P/TBV Ratio	6.27	5.16	5.65	5.15	3.64	5.14
P/FCF Ratio	101.44	83.58	69.82	58.86	66.03	71.70
P/OCF Ratio	43.17	35.57	28.84	33.23	25.51	31.58
PEG Ratio	1.41	1.32	0.93	1.00	2.96	3.85

EV Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
EV/Sales Ratio	4.97	4.36	4.45	4.39	3.21	4.54
EV/EBITDA Ratio	22.13	20.95	23.09	26.76	21.22	20.75
EV/EBIT Ratio	27.04	25.90	29.38	36.30	28.55	24.98
EV/FCF Ratio	103.64	86.59	72.96	63.48	64.49	70.14

Financial Efficiency

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Debt / Equity Ratio	0.09	0.09	0.16	0.19	0.25	0.15
Debt / EBITDA Ratio	0.35	0.40	0.78	1.12	1.55	0.63
Debt / FCF Ratio	-	1.66	2.50	2.70	4.76	2.14
Net Debt / Equity Ratio	-0.04	-0.04	0.03	0.08	-0.12	-0.10
Net Debt / EBITDA Ratio	-0.17	-0.19	0.15	0.46	-0.73	-0.43
Net Debt / FCF Ratio	-	-0.80	0.47	1.10	-2.23	-1.47
Asset Turnover	-	0.80	0.78	0.78	0.77	0.85
Inventory Turnover	-	1.20	1.23	1.35	1.40	1.28
Quick Ratio	-	1.48	1.36	1.17	1.86	1.70
Current Ratio	-	2.76	2.63	2.35	2.87	3.04
Return on Equity (ROE)	-	13.22%	9.74%	7.67%	8.36%	17.35%
Return on Assets (ROA)	-	8.42%	7.41%	5.91%	5.41%	9.67%
Return on Invested Capital (ROIC)	15.53%	13.83%	11.12%	8.62%	9.01%	18.36%
Return on Capital Employed (ROCE)	-	16.10%	14.50%	10.70%	10.30%	17.20%

Yields

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Earnings Yield	2.66%	2.81%	1.94%	1.74%	2.29%	3.27%
FCF Yield	0.99%	1.20%	1.43%	1.70%	1.51%	1.40%
Dividend Yield	0.31%	0.38%	0.27%	0.33%	0.50%	0.38%
Payout Ratio	-	4.59%	13.76%	9.27%	21.53%	11.48%
Buyback Yield / Dilution	0.02%	-	-	-	-	-0.17%
Total Shareholder Return	0.33%	0.38%	0.27%	0.33%	0.50%	0.21%

Data Source: S&P Global Market Intelligence Last updated: Aug 13, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 30, 2026

Data Sources Report a data error